A new approach in the hormonal treatment of prostate cancer: complete instead of partial blockade of androgens.
暂无分享,去创建一个
[1] K. Walker,et al. THERAPEUTIC POTENTIAL OF THE LHRH AGONIST, ICI 118630, IN THE TREATMENT OF ADVANCED PROSTATIC CARCINOMA , 1983, The Lancet.
[2] G. Murphy,et al. A decade of experience with chemotherapy for prostate cancer. , 1983, Urology.
[3] J. Wass,et al. Treatment with gonadotrophin releasing hormone analogue in advanced prostatic cancer. , 1983, British medical journal.
[4] D Ackman,et al. Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[5] P. Kelly,et al. Antifertility effects of LHRH agonists in the male rat and inhibition of testicular steroidogenesis in man. , 1980, International journal of fertility.
[6] P. Kelly,et al. Inhibitory Effect of LHRH and Its Agonists on Testicular Gonadotrophin Receptors and Spermatogenesis in the Rat , 1978 .
[7] C. Huggins,et al. Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate , 1941, CA: a cancer journal for clinicians.
[8] F. Labrie,et al. New approach in the treatment of prostate cancer: Complete instead of partial withdrawal of androgens , 1983, The Prostate.
[9] F. Labrie,et al. Combined long‐term treatment with an LHRH agonist and a pure antiandrogen blocks androgenic influence in the rat , 1982, The Prostate.